Partial-Coated T1 MRI Nanoparticles for Stable Dispersion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing T1 MRI contrast agents face challenges with dispersion stability and contrast ability due to fast molecule movement and low surface area-volume ratio, limiting their effectiveness in MRI imaging.
Innovation Solution
A method involving the partial coating of a T1 contrast material on a nanoparticle support with hydrophilic functional groups, using materials like organic polymers or silica, to create nanoparticles with improved stability and contrast ability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If metal chelate-based materials are used as T1 contrast agents, then the contrast effect is enhanced, but the dispersion stability deteriorates due to fast molecule movement
Solution Approach 1:
The patent combines metal chelate-based T1 contrast materials with nanoparticle supports to create composite nanoparticle contrast agents. This composite structure allows the contrast material to maintain its contrast-enhancing properties while the nanoparticle support provides structural stability and controlled relaxation rates, resolving the contradiction between contrast effect and dispersion stability
Solution Approach 2:
The patent changes the physical parameters of the contrast agent by transitioning from small metal chelate molecules to nanoparticle-sized structures. This size parameter change slows down molecular movement (tumbling rate), which simultaneously maintains contrast effectiveness while improving dispersion stability and preventing rapid relaxation
2Stability of the object's composition
If metal oxide-based nanoparticles are used, then the molecule movement is slowed, but the contrast effect is restricted due to low surface area-volume ratio
Solution Approach 1:
The patent utilizes nanoparticle supports with high surface area-to-volume ratios that can be engineered to have porous or high-surface-area structures. This increases the surface area available for contrast material interaction while maintaining the slow molecule movement characteristics of nanoparticle-sized structures, thereby improving contrast effect without sacrificing stability
Solution Approach 2:
The patent creates composite structures combining metal oxide nanoparticles with high-surface-area materials or porous structures, allowing the system to benefit from both the slow molecule movement of metal oxides and the enhanced surface area needed for strong contrast effects
3Reliability
If the nanoparticle size is reduced to increase surface area, then the contrast ability is improved, but the dispersion stability worsens due to increased Brownian motion
Solution Approach 1:
The patent optimizes the nanoparticle size parameter to achieve a balance point where the surface area is sufficiently large for good contrast ability while the size remains large enough to minimize excessive Brownian motion. This parameter optimization resolves the contradiction between contrast ability and dispersion stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enhances the dispersion stability and contrast ability of T1 MRI contrast agents, maintaining stability across varying NaCl concentrations, pH levels, and temperatures, with improved T1 relaxivity.
Implementation Method 1
T1 contrast agents are composed of paramagnetic materials capable of inducing spin-lattice relaxation
Implementation Method 2
selecting a support material capable of, when particlized, exposing hydrophilic chemical functional groups on a surface
Data Source
AI summary
The present invention improves an existing contrast agent, especially, a T1 contrast agent, and adopts a strategy in which the T1 contrast material is partially coated on a support surface to which a hydrophilic functional group is exposed. The partial coating strategy adopted in the present invention improves both the stability and contrast performance of T1 contrast agent nanoparticles, and such a strategy leads to very interesting technical development.